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Abstract
Mitochondrial permeability transition pore (mPTP) opening is critical for ischemia / reperfu-
sion (I/R) injury and is associated with increased [Ca2+] and reactive oxygen species (ROS).
Here we employ surface fluorescence to establish the temporal sequence of these events in
beating perfused hearts subject to global I/R. A bespoke fluorimeter was used to synchro-
nously monitor surface fluorescence and reflectance of Langendorff-perfused rat hearts at
multiple wavelengths, with simultaneous measurements of hemodynamic function. Potential
interference by motion artefacts and internal filtering was assessed and minimised. Re-oxi-
dation of NAD(P)H and flavoproteins on reperfusion (detected using autofluorescence) was
rapid (t0.5 < 15 s) and significantly slower following ischemic preconditioning (IP). This
argues against superoxide production from reduced Complex 1 being a critical mediator of
initial mPTP opening during early reperfusion. Furthermore, MitoPY1 (a mitochondria-tar-
geted H2O2-sensitive fluorescent probe) and aconitase activity measurements failed to
detect matrix ROS increases during early reperfusion. However, two different fluorescent
cytosolic ROS probes did detect ROS increases after 2–3 min of reperfusion, which was
shown to be after initiation of mPTP opening. Cyclosporin A (CsA) and IP attenuated these
responses and reduced infarct size. [Ca2+]i (monitored with Indo-1) increased progressively
during ischemia, but dropped rapidly within 90 s of reperfusion when total mitochondrial
[Ca2+] was shown to be increased. These early changes in [Ca2+] were not attenuated by IP,
but substantial [Ca2+] increases were observed after 2–3 min reperfusion and these were
prevented by both IP and CsA. Our data suggest that the major increases in ROS and [Ca2
+] detected later in reperfusion are secondary to mPTP opening. If earlier IP-sensitive
changes occur that might trigger initial mPTP opening they are below our limit of detection.
Rather, we suggest that IP may inhibit initial mPTP opening by alternative mechanisms
such as prevention of hexokinase 2 dissociation from mitochondria during ischemia.
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Introduction
Reperfusion of the heart following prolonged ischemia causes irreversible damage through
myocyte death and resulting infarct formation. Critical to this process is opening of the mito-
chondrial permeability transition pore (mPTP) that occurs after about 2 min of reperfusion,
when the intracellular pH (pHi) returns to preischemic values from the low ischemic values
(<6.5) that inhibit mPTP opening [1,2]. MPTP opening compromises cellular bioenergetics,
impairing restoration of ionic homeostasis, including [Ca2+], while also increasing reactive
oxygen species (ROS) production. These effects together produce further mPTP opening and
bioenergetic compromise leading to a spreading wave of necrotic cell death that constitutes
the infarct [3,4]. Cardioprotection is afforded by pharmacological inhibition of mPTP opening
by Cyclosporin A (CsA) [5], Sanglifehrin A [6] or cinnamic anilides [7], as well as by regimes
such as ischemic preconditioning (IP) and post-conditioning which also act, at least in part, by
preventing mPTP opening [3,4].
Although the exact molecular composition of the mPTP remains uncertain [8–10], it is well
established that its opening is triggered by elevated matrix [Ca2+], while the sensitivity to [Ca2
+] is greatly increased by oxidative stress, elevated phosphate and decreased matrix adenine
nucleotides [3]. These are all conditions associated with ischemia / reperfusion (I/R), and we,
like many others, have proposed that the main triggers for mPTP opening during early reper-
fusion are an increased matrix [Ca2+] together with mitochondrial ROS production [3,8]. Fur-
thermore, it has been proposed that IP reduces or prevents mPTP opening, and thus I/R
injury, by attenuating these triggers [3,11]. While evidence in support of this view has come
from studies on isolated cardiac myocytes subject to simulated I/R [12,13], we were concerned
that the conditions experienced by isolated myocytes subject to simulated I/R do not ade-
quately reproduce those occurring in the intact heart subject to I/R. In particular, the beating
perfused heart exhibits much higher metabolic turnover and calcium cycling rates than iso-
lated cardiac myoctes which also cannot mimic the complex cell / cell interactions occurring
in the whole heart. Hence we wished to monitor ROS and [Ca2+] dynamics in the perfused
beating heart subject to I/R.
Others have monitored dihydroethidium (DHE) surface fluorescence of the perfused heart
to detect ROS production during I/R [14,15]. However, major concerns have been expressed
over the use of DHE as a ROS probe, both in terms of whether the fluorescent species moni-
tored really detects superoxide [16] and its sensitivity to changes in mitochondrial membrane
potential [17]. The luminescent probe lucigenin has also been employed which did detect a
large increase in ROS during reperfusion, but this only reached a peak after about 5 min of
reperfusion [17] which is after mPTP opening [1,2]. Others have used multi-photon micros-
copy to measure changes of [Ca2+] and ROS in the perfused heart [18], but in these studies
pharmacological inhibition of contractile function was required. This would have greatly
reduced ATP turnover and thus the energetic demand on mitochondria which may well have
caused substantial modulation of the kinetics of mPTP opening during reperfusion when com-
pared to the beating heart. Although sophisticated gating mechanisms can be employed in the
beating heart to correct for motion artefacts [19], such an approach would only report changes
in a few cardiomyoctes and thus might not reflect the behaviour of the majority. Others have
used mass spectrometry probes or protein carbonylation to detect increases in mitochondrial
superoxide and other ROS species during reperfusion [11,20]. However, these techniques
required the hearts to be freeze-clamped at a specific time and, unlike continuous fluorescent
measurements, do not have the time resolution to detect whether this ROS increase precedes
or follows mPTP opening.
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Here, we report data from experiments in which we continuously monitored surface fluo-
rescence of the beating heart at multiple excitation and emission wavelengths using a
bespoke fluorimeter that also monitors surface reflectance. We have measured endogenous
NAD(P)H and flavoprotein fluorescence as well as intracellular [Ca2+] with Indo-1 and
ROS with both cytosolic and mitochondria-targeted ROS probes. In parallel we measured
aconitase activity and total [Ca2+] in mitochondria isolated after 90 s reperfusion as addi-
tional indicators of mitochondrial ROS and [Ca2+] changes. Contrary to our expectations,
we were unable to detect a significant increases in ROS until after about 1.5–2 min of reper-
fusion, which was after mPTP opening had occurred. Furthermore, the progressive increase
in ROS seen after this time point in reperfusion was attenuated by inhibiting mPTP opening
with Cyclosporin A (CsA) or IP, both of which reduced infarct size. Measurement of [Ca2+]i
with Indo-1 showed it to increase progressively during ischemia, and drop rapidly within 90
s of reperfusion when total mitochondrial [Ca2+] was increased. While these early changes
in [Ca2+] were not attenuated by IP, a substantial [Ca2+] increase was observed after 2–3
min reperfusion that was prevented by both IP and CsA and thus likely to be secondary to
mPTP opening. We conclude that any early IP-sensitive changes in [Ca2+] and ROS that
might trigger initial mPTP opening are too small to be detected. Rather, we propose that IP
may inhibit initial mPTP opening by alternative mechanisms such as prevention of hexoki-
nase 2 dissociation from mitochondria during ischemia [21,22]. Subsequent increases in
ROS and [Ca2+] follow this initial mPTP opening and so are also attenuated by IP. This may
prevent a progressive cycle of mPTP opening, ROS production and calcium overload that
would lead to infarct formation.
Materials and Methods
Materials
Unless otherwise stated chemicals and reagents used in this study were purchased from
Sigma-Aldrich (St. Louis, MO) or Fisher Scientific UK. 5-carboxy-2’,7’-dichlorofluoroscein
diacetate, di(acetoxymethyl ester) was from Anaspec (Fremont, CA), but is no longer commer-
cially available. Calcein-AM was from Biotium (Hayward, CA), MitoPY1 and PO1 from Tocris
Bioscience (R & D Systems Europe LTD, Abingdon, UK) and Indo-1-AM from TEFLabs (Aus-
tin, TX). Invitrogen/Molecular Probes (Eugene, OR) supplied Pluronic F-127, Fura-FF—pen-
tapotassium salt, dihydroethidium, 2’,7’-dichlorodihydrofluorescein diacetate, 6-carboxy-2’,7’-
dichlorodihydrofluorescein diacetate, 6-carboxy-2’,7’-dichlorodihydrofluorescein diacetate, di
(acetoxymethyl ester) and MitoTracker Deep Red FM.
Methods
Langendorff heart perfusion. All procedures conformed to the UK Animals (Scientific
Procedures) Act 1986 and the guidelines from the Directive 2010/63/EU of the European Par-
liament and were approved by the local ethical committees of the University of Bristol (UB/09/
012) and University of Bordeaux (Authorization number A33-318-2). Hearts from male Wis-
tar rats (250–300 g) were perfused with Krebs–Henseleit Buffer (KHB) in Langendorff mode
at constant flow (12 mL/min) with hemodynamic function determined using a water-filled
latex balloon inserted into the left ventricle essentially as described previously [23]. IP was elic-
ited by two cycles of 5 min of global ischemia prior to 30 min global (index) ischemia as sum-
marised schematically in Fig 1. After 120 min reperfusion hearts were analysed for infarct size
using 2’,3’,5’-triphenyltetrazolium chloride (TTC) staining [21]. A more extensive description
of the methods used of the techniques used for heart perfusion is provided in Supporing
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Information. Measurement of heart succinate content was performed by freeze-clamping the
heart followed by acidic extraction of metabolites as described previously [21] and enzymatic
assay of succinate [24].
Whole heart surface fluorescence measurements. Epicardial fluorescence was moni-
tored using a spinning-wheel fluorimeter designed and custom-built by the authors (PP and
APH) in collaboration with Cairn Research Ltd, Faversham, Kent, ME13 8UP. For these exper-
iments, a modified perfusion apparatus was employed that was contained within a light-proof
box accommodating the optic fiber from the fluorimeter. This optic fibre was placed at 2–3
mm distance from the left ventricular wall of the heart which was maintained at 37˚C in a
water jacketed and humidified Plexiglas perfusion chamber throughout the perfusion. The
equipment is shown in Fig 2A and 2B and illustrated schematically in Fig 2C. Details of the fil-
ters used are given in S1 Table which also includes photomultiplier voltage settings. A more
Fig 1. Perfusion protocols used for fluorescence measurements. A, A 30 min dye loading protocol was used
for loading the heart with 5 μmol/L 5-cH2DCFDA, diAM, 0.4 μmol/L calcein-AM or 3 μmol/L MitoPY1. B, A 45 min
dye loading protocol with recirculation was used to load the heart with 3 μmol/L Indo-1. C, Hearts were perfused with
5 μmol/L PO1 for 30 min before index ischemia and 30 min on reperfusion. Further details are given in Supporting
Information.
doi:10.1371/journal.pone.0167300.g001
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extensive description of the equipment and techniques used for surface fluorescence measure-
ments is provided in Supporting Information.
Autofluorescence of NAD(P)H and flavoproteins. These were measured using excita-
tion at 340 and 460 nm and emission 485 and 535 nm, respectively. For measurements of the
rapid changes of autofluorescence seen on reperfusion data were collected continuously at 10
Hz for the last 15 s of ischemia and the first 2 min of reperfusion.
ROS and [Ca2+] measurements. The fluorescent dyes used to monitor ROS were 5-car-
boxy-2’,7’-dichlorodihydrofluorescein diacetate, di(acetoxymethyl ester) (5-cH2DCFDA,
diAM Ex 485 nm, Em 535 nm), Peroxy-Orange 1 (PO1, Ex 535 nm, Em 615 nm) and Mito-
chondria Peroxy-Yellow 1 (MitoPY1, Ex 485 nm, Em 535 nm) while Indo-1-AM (Ex 340 nm
Em 405 nm and 485 nm) was used to monitor [Ca2+]. Calcein-AM (Ex 485 nm, Em 535 nm)
was employed as a negative control. The protocols used to load these dyes are shown in Fig 1
and it should be noted that for the protocols shown in Fig 1A and 1B, 10 nmol/L insulin was
present in the KHB perfusion medium during dye loading to maintain glycogen levels over the
extended pre-ischemic perfusion period. In its absence glycogen became depleted and this
gave significant cardioprotection [21,25]. For PO1 the dye was not pre-loaded, but present
throughout the perfusion (Fig 1C) and insulin was not required. In all experiments employing
probes loaded in their acetoxymethyl ester (AM) form, the KHB was also supplemented with
Fig 2. Design of the bespoke surface fluorescence apparatus. A, Picture of the interior of the light-proof
box showing the water jacketed perfusion chamber containing a Langendorff-perfused rat heart. B, Zoom in of the
perfusion chamber to show that the light is shining on the surface of the left ventricular free wall and that motion
artefact was minimized by placing hearts’ apex in a small retaining cup. C, Schematic of the optics. Insert shows
alternative configuration for measuring surface fluorescence spectra by switching between the 440 DCLP dichroic
mirror for filter based measurements and a 100% reflecting mirror for fluorescence spectrum measurements.
doi:10.1371/journal.pone.0167300.g002
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0.1 mmol/L probenecid to limit dye leakage while Pluronic F-127 was added to the stock solu-
tions of the dyes to aid their solubilisation. Dye loading started about 7–8 min after the heart
cannulation and was preceded by measurement of background fluorescence for 3–5 min.
Cardiomyocyte isolation and confocal imaging of MitoPy1. Rat ventricular myocytes
were isolated from male Wistar Rats (250g) with a modified Langendorff method as described
previously [26]. Cells were immobilised on laminin-coated round glass coverslips, cultured in
6-well plates in medium M199 and used immediately following isolation or after an overnight
incubation. Myocytes were washed into HEPES-bufffered saline solution containing (in
mmol/L): NaCl 130, HEPES 25, KCl 5, glucose 10, MgCl2 1, and CaCl2 1.8 and loaded with
MitoTracker Deep Red (200 nmol/L) in the presence or absence of 14 μmol/L MitoPY1 for
30 min at 37˚C. Confocal microscopy was carried out on a Leica SP-5 microscope (63.0 x1.40
Oil) at 37˚C in the Woolfson Bio-imaging Centre at the University of Bristol (http://www.
bristol.ac.uk/wolfson-bioimaging/). After loading, 2.5 ml HEPES-bufffered saline solution was
added to the cells. H2O2 was added directly to the coverslips (final concentration 100 μmol/L),
incubated for 10 minutes and the cells were imaged again. MitoPY1 was excited by Argon
laser (514 nm line, 100%) and its fluorescence was collected at 520–570 nm. MitoTracker
Deep Red was excited by HeNe laser (633 nm line, 4.1%) and its fluorescence was collected at
640–700 nm.
Isolation of heart mitochondria. Mitochondria were isolated from rat hearts as described
previously [21] using Dounce-Potter homogenisation of protease-treated tissue in isolation
medium (300 mmol/L sucrose, 10 mmol/L Tris, 2 mmol/L EGTA pH 7.4 at 4˚C), followed by
differential centrifugation and Percoll (25%) gradient centrifugation.
Measurement of ROS production and mPTP opening in isolated mitochondria. Open-
ing of the mPTP was followed at 25˚C in energised mitochondria as described previously [27]
using fluorescence measurements of extramitochondrial [Ca2+] (Fura-FF) and ΔC (Rhoda-
mine-123) together with light scattering (LS) at 560 nm monitored continuously with a Cairn
Research spinning-wheel multiwavelength fluorimeter. The buffer (pH 7.2) contained (in
mmol/L): KCl 125, MOPS 20, Tris 10, KH2PO4 2.5 plus 10 μmol/L EGTA, 1 μmol/L Fura-FF
pentapotassium salt, 100 nmol/L Rhodamine-123 and respiratory substrates (5 mmol/L L-glu-
tamate + 2 mmol/L L-malate + 5 mmol/L succinate (GMS)). H2O2 production was measured
immediately afterwards in the same apparatus using Amplex Red (10 μmol/L) and peroxidase
(0.1 mg/mL) as described previously [28] but with simultaneous monitoring of LS.
Measurement of mitochondrial enzymes activities and total calcium content. Mito-
chondria were isolated from rat hearts as described above using a modified isolation buffer
lacking EGTA but enriched with 0.2 μmol/L of Cyclosporin A, 0.5 μmol/L of ruthenium red
and 2 mg/mL of free fatty acid BSA. At the end of the perfusion protocol (S1 Fig), the heart
was flushed with 12 mL of modified isolation buffer at 4˚C prior to mitochondrial isolation.
Mitochondria were divided into aliquots and immediately frozen in liquid nitrogen for further
biochemical measurements. Citrate synthase activity was assessed as previously described [21]
while aconitase activity was determined at 37˚C using a modification of that described by
Chouchani et al. [20]. The assay buffer used was: KH2PO4 50 mmol/L; Triton X-100 0.1%
(w/v); NADP+ 0.2 mmol/L; MnCl2 0.6 mmol/L, pH 7.4 with KOH. Purified mitochondria
were incubated in 1 mL of the assay buffer supplemented with 2 units/mL of NADP-depen-
dent isocitrate dehydrogenase (Leebio products). The reaction was started by the addition of
5 mmol/L of sodium-citrate (pH 7.4) and the production of NADPH followed at 340 nm. In
the absence of citrate no NADPH production was detected. To evaluate aconitase sensitivity to
H2O2 in the different groups mitochondria were incubated for 5 min on ice in the presence of
200 μmol/L of H2O2. The assay was then performed as described above (final H2O2 concentra-
tion in the cuvette 20 μmol/L).
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For determination of total calcium content, 200 μg of the mitochondria were mixed with an
equal volume of 0.6 mol/L HCl. The mixture was then sonicated two times for 10 s at full
power using a Fisherbrand FB15062 sonicator interspersed with a 10 s rest interval. The final
homogenate was used to evaluate mitochondrial total calcium content (expressed as ngatoms/
mg protein) using the α-cresolphthalein complexone assay (Cayman Chemical), according to
the manufacturer’s instructions. Preliminary experiments were performed to confirm that
15 μL of a mixture containing an equal volume of modified ISA and 0.6 mol/L HCl did not
alter the pH of the assay buffer (210 μL final volume in the well).
Measurement of mPTP opening in hearts using mitochondrial calcein retention. After
the stabilization period, Langendorff-perfused hearts were loaded for 10 min with 0.4 μmol/L
final of calcein-AM (see S1 Fig). Purified mitochondria (300 to 500 μg) were resuspended in 2
ml final of assay buffer (KH2PO4 33 mmol/L, Triton X-100 0.1% (w/v), pH 7.2) in order to
determine the calcein emission spectra using a Xenius fluorimeter (Safas, Monaco) with the
following settings: PMT = 900 volts, bandwidth = 10 nm, Ex 493 nm, Em scanned from 505 to
540 nm with a 0.2 nm increment. The maximum emission obtained in the different popula-
tions of mitochondria were calibrated using a standard curve obtained using known quantities
of calcein. Mitochondrial calcein content was expressed as nmol per mg protein. Background
fluorescence was determined in parallel experiments with mitochondria isolated from hearts
(n = 3) subjected to a mock loading (DMSO vehicle only).
Statistical analysis
Data are presented as means ± SEM for the number of separate heart perfusions or mitochon-
drial preparations indicated. Statistical analysis was performed using the relevant functions in
Excel, GraphPad Prism 6 or SPSS 17.0. For real-time fluorescence traces, a 2-tailed t-test was
employed to determine the significance of differences between control and IP or drug-treated
hearts. An F-test was used first to check the variances and if unequal a heteroscedastic t-test
was used. For analysis of differences in infarct size and hemodynamic function between groups
a 1-way ANOVA followed by Tukey’s multiple comparisons test was used.
Results
Validation of the surface fluorescence measurements
We first validated the use of our bespoke surface fluorescence apparatus by monitoring the
changes in NAD(P)H and flavoprotein autofluorescence during ischemia and reperfusion (Fig
3A). Upon ischemia, we observed the expected rapid change in reduction state of both NAD
(P)H (increase in 340ex / 485em fluorescence) and flavoproteins (decrease in 460ex / 535em fluo-
rescence) and their re-oxidation during reperfusion. An important feature of our optical con-
figuration is that we can measure the reflectance of light at the wavelengths used for both
excitation and emission. These signals, included in Fig 3A, will change in response to both the
geometry of the heart surface and the internal filtering caused by changes in the absorbance of
endogenous chromophores such as myoglobin and cytochromes. However, changes in light
scattering dominate because the optic fibre is held 2–3 mm from the surface of the heart to
avoid contact artefacts (see Fig 2B). This is apparent in Fig 3A where the reflectance signals at
all wavelengths decrease during ischemic contracture (increase in ventricular pressure) which
causes the surface geometry of the heart to change. Importantly, contracture caused no signifi-
cant change in the fluorescence signals implying that changes in surface geometry are not sig-
nificantly affecting our fluorescence measurements.
We also carried out experiments with rapid data collection to confirm that we could detect
beat by beat changes in cytosolic [Ca2+], determined using Indo-1 fluorescence (Fig 3B). By
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using a ratiometric dual emission dye, movement artefacts are minimised because detection of
emitted light at both wavelengths is simultaneous, and both are subjected to the same changes
in optical geometry caused by the heart beat. Transient changes in the 405/485 nm fluores-
cence emission ratio of Indo-1 were detected that exactly followed changes in developed pres-
sure monitored using a latex balloon inserted in the left ventricle.
As noted above, another potential artefact that might interfere with fluorescent measure-
ments during ischemia and reperfusion is a change in the internal filtering exerted by myoglo-
bin and cytochromes absorbance as they undergo oxygenation / de-oxygenation and oxidation /
reduction [17,29]. The most intense absorbance by oxymyoglobin and deoxymyoglobin
(absorbance maxima at 420 and 440 nm respectively [30]) occurs outside the range of all dyes
used except for Indo-1, and in this case the 405/485 nm emission ratio was employed. This
should be relatively insensitive to myoglobin oxygenation state since the 405/485 absorbance
ratios of oxymyoglobin and deoxymyoglobin are similar. Furthermore, signals were corrected
for autofluorescence by performing parallel experiments with unloaded hearts under identical
conditions and instrument settings. In order to assess the extent to which changes in internal
filtering might affect fluorescence signals of probes employed in our studies that are excited
and emitting at higher wavelengths, we measured surface emission spectra under normoxic
conditions and at different times of ischemia and reperfusion. These data are presented in
Fig 4 which also includes the wavelength bandwidths of the emission filters we employed.
Changes in fluorescence spectra were observed within the first 30 s of ischemia and were rap-
idly reversed on reperfusion. These changes are likely to be caused by modifications of the
internal filtering by myoglobin as it moves between its oxy- and deoxy- state. Indeed, myoglo-
bin is known to be rapidly de-oxygenated upon ischemia (t0.5, 6 s) with 90% equilibration
reached at 12 s; re-oxygenation at reperfusion occurs at a similar rate [17]. Thus some caution
must be employed when interpreting data obtained within the first 10 s or so of ischemia or
reperfusion, when the major changes in myoglobin oxygenation state and thus internal filter-
ing occur. However, this is unlikely to account for any differences observed between control
and IP hearts whose rates of myoglobin deoxygenation and oxygenation would not be
expected to differ greatly. Furthermore,after about 10 s of reperfusion, comparison of fluores-
cent signals between control and IP hearts should be unaffected by changes in either internal
filtering or surface geometry under our experimental conditions.
ROS measurements
We explored the use of several fluorescent probes that detect different forms of ROS, including
dihydroethidium and several dichlorodihydrofluorescein dyes, but found the majority to be
unsatisfactory for use with the perfused rat heart for a variety of reasons as outlined in Sup-
porting Information. Nevertheless, we found that 5-carboxy-2’, 7’-dichlorodihydrofluorescein
diacetate (5-cH2DCFDA) in its diAM form consistently loaded into the heart and was quite
well retained as illustrated in Fig 5A. However, there is some debate as to the mechanism of
2’,7’-dichlorodihydrofluorescein oxidation in cells and even whether it is suitable to monitor
ROS levels [31,32]. Thus we also explored the use of boronate cage reagents have been devel-
oped whose fluorescence responds specifically to H2O2 [33].
Fig 3. Validation of the bespoke surface fluorescence apparatus. A, Time course of NAD(P)H (top) and
flavoprotein (bottom) surface fluorescence and the reflectance signals at the corresponding excitation and
emission wavelengths together with data for the left ventricular pressure (LVP). B, Example of Indo-1
fluorescence transients recorded at 405 nm (in blue) and at 485 nm (in red), and Indo-1 ratio calculated after
subtracting background autofluorescence. The top trace shows corresponding LVP data.
doi:10.1371/journal.pone.0167300.g003
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IP attenuates 5-cH2DCFDA oxidation during reperfusion
Fig 5A presents typical 5-cH2DCFDA fluorescence traces for non-ischemic and ischemic
hearts without (control) and with IP. In order to discriminate between fluorescence artefacts
caused by changes in internal filtering and real ROS related changes in fluorescence, parallel
experiments were performed using hearts loaded with the ROS-insensitive dye, calcein (Fig
5B), whose fluorescence properties closely match those of 5-cDCFDA. Comparison of the
Fig 4. Surface fluorescence spectra of hearts at different stages of dye loading and ischemia-reperfusion
protocols. A, PO1 perfused hearts; B, Calcein loaded hearts; C, Indo-1 loaded hearts. The coloured shaded areas
indicate the band passes of the filters used for excitation and emission in the filter wheel mode of operation (see S1
Table for details).
doi:10.1371/journal.pone.0167300.g004
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Fig 5. ROS measurements using 5-cDCF surface fluorescence in control and IP hearts during ischemia /
reperfusion A, Typical traces for 5-cH2DCFDA, diAM loaded control and IP hearts. B, Parallel data for hearts
loaded with the ROS-insensitive dye, calcein-AM. The signal from a non-ischemic 5-cH2DCFDA, diAM loaded heart
(A, dark grey trace) demonstrates good dye retention during the time of the experiment. C and D, Mean data (±
SEM, error bars) of 6 hearts loaded with 5-cH2DCFDA, diAM (C) or calcein-AM (D). Signals were normalized using
the mean fluorescence value obtained after 1 min of reperfusion. Note that loss of calcein signal with time is due to
dye leakage and occurs even in normoxia. Statistically significant effects of IP are shown by the horizontal lines (**
p 0.01; * p 0.05). Corresponding infarct sizes are presented in Table 1.
doi:10.1371/journal.pone.0167300.g005
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5-cDCFDA and calcein data (Fig 5A vs. 5B) reveals that the very rapid changes of 5-cDCFDA
fluorescence at the onset of ischemia and reperfusion are unlikely to be related to ROS produc-
tion. Rather, they are probably caused by changes in myoglobin absorbance as seen in the fluo-
rescence emission spectra (Fig 4B). However, the slower increase in 5-cDCFDA fluorescence
on reperfusion is not seen with calcein and thus would appear to report a real increase in ROS
which is largely prevented by IP. Fig 5C presents mean data (± SEM) of 6 separate experiments
for control and IP hearts. To correct for slight differences in dye loading between hearts, data
were normalized to the fluorescence signal at 1 min of reperfusion. In control hearts, a short
transient increase in 5-cDCFDA signal is seen between 1.5 and 2 min followed after 4.2 min by
a significant and progressive rise in fluorescence that is not seen in IP hearts (p 0.01). Infarct
size data for these hearts after 2 hours reperfusion are reported in Table 1 and confirm that IP
was strongly cardioprotective under these conditions (15.3 ± 1.4% vs. 60.3 ± 5.4%). The
observed increase in 5-cDCFDA fluorescence was not accompanied by a parallel increase in
the calcein signal which showed no significant difference between control and IP hearts (Fig
5D). Note that loss of calcein signal with time is due to dye leakage and occurs even in nor-
moxia. The similar dye leakage between control and IP hearts suggests that at the early stage of
reperfusion myocyte plasma membranes integrity is similar in control and IP hearts.
IP attenuates PO1-detectable hydrogen peroxide production during
reperfusion
We first employed PO1 (535ex / 615em) to measure global H2O2 in the heart during ischemia
and reperfusion and Fig 6A presents normalised mean data (± SEM) for control and IP hearts.
The data show that PO1 was taken up by the perfused heart but not retained upon wash out and
therefore must be present in the perfusion medium throughout the experiment. Very rapid
decreases in PO1 fluorescent signals were observed upon ischemia with an equally rapid reversal
on reperfusion. These changes are similar, but in reverse direction, to those seen for 5-cDCFDA
and calcein and might be the result of changes in internal filtering by cytochromes a and a3 that
have a reduced minus oxidised absorbance maximum of 606 nm in intact mitochondria [34].
This is consistent with the rapid change in fluorescence emission spectra of PO1 shown in Fig
4A. However, we observed an additional, slower increase in PO1 fluorescence that began after
about 2–3 min of reperfusion and was greatly inhibited by IP as shown in Fig 6B. This response
is very similar to that seen with 5-cDCF (Fig 5C). In a separate set of experiments we investi-
gated the effects of adding 0.2 μmol/L Cyclosporin A (CsA), to inhibit mPTP opening, on the
increase in PO1 fluorescence during reperfusion. Fig 6C shows that the increase in signal was
diminished, but the effect was much less profound than that induced by IP and only clearly visi-
ble after about 8 min as shown in Fig 6D. This is not unexpected since, as reported in Table 1,
CsA gave less reduction in infarct size (25.5 ± 1.7% from 38.6 ± 3.0%) than IP (10.4 ± 0.6% from
44.4 ± 3.2%) which is consistent with CsA being less effective than IP at preventing mPTP open-
ing as measured by the mitochondrial deoxyglucose entrapment technique [23].
Neither MitoPY1 nor aconitase activity detect increased mitochondrial
H2O2 early in reperfusion
In order to measure changes in mitochondrial matrix ROS during reperfusion we first employed
MitoPY1, a boronate-cage H2O2-specific fluorescent probe that is targeted to mitochondria
using the positively charged triphenylphosphonium group [35]. We established that MitoPY1 is
correctly targeted to mitochondria in isolated cardiac myocytes and confirmed that it responded
to H2O2 (Fig 7). We then loaded MitoPY1 into the Langendorff-perfused hearts and demon-
strated that it responded to added H2O2 in this setting (Fig 8A). However, unlike for PO1 and
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5-cDCFDA, we were unable to demonstrate any significant changes between control and IP
hearts in the small fluorescence increase upon reperfusion (Fig 8B). Although there appeared to
be a trend towards a lower signal in the IP hearts, the data of Fig 8C suggest this is probably
caused by changes in autofluorescence rather than MitoPY1 itself. It should also be noted that
the MitoPY1-loaded IP hearts showed a significantly greater infarct size than unloaded hearts
(Table 1) suggesting that MitoPY1 loading might attenuate the effects of IP by some unidentified
mechanism. Overall, we conclude that the small changes in the MitoPY1 signal observed were
more likely to represents changes in flavoprotein autofluorescence (485 nm excitation) and that
any increase in matrix H2O2 upon reperfusion is below our limit of detection.
Further evidence against any major increases in mitochondrial ROS occurring during early
reperfusion was obtained by measuring aconitase activity in mitochondria isolated after 90 s of
reperfusion. No significant differences in activity were detected between pre-ischemic and 90 s
reperfused samples, whereas treatment of the mitochondrial extracts (at 0˚C) with 200 μmol/L
H2O2 did reduce enzyme activity by about 20% (Fig 8D). Significant decreases (~50%) in aconi-
tase activity on reperfusion have been detected by others [20], but the earliest time point measured
was after 15 min of reperfusion when our PO1 and 5-cDCF data also detect increases in ROS.
The effects of IP on tissue succinate and autofluorescence are
inconsistent with complex 1 mediated generation of matrix superoxide in
early reperfusion
Chouchani et al. have proposed that superoxide production occurs early in reperfusion from
the matrix face of Complex 1 which they suggest is maintained in a highly reduced state by
Table 1. Infarct size and hemodynamic recovery of hearts in all experiments.
Control IP
Infarct size RPP RPP LVEDP Infarct size RPP RPP LVEDP
(% of whole (mmHg*beat recovery (mmHg) (% of whole (mmHg*beat recovery (mmHg)
Fluorophore Ins1 N heart) /min) (%) n heart) /min) (%)
5cDCF + 6 60.3 ± 5.4 22151 ± 2037 10.9 ± 2.1 61.9 ± 4.5 6 15.3 ± 1.4 ** 22230 ± 1559 59.5 ± 5 ** 35.7 ± 4.5 **
PO1 - 11 44.4 ± 3.2 27825 ± 1714 27 ± 4.6 74.7 ± 5.7 9 10.4 ± 0.6 ** 27416 ± 1444 102 ± 7.9 ** 15.1 ± 2 **
PO1 - 17 38.6 ± 3 28269 ± 1164 28.3 ± 3.7 73.4 ± 1 - - - - -
PO1 + CsA - 16 25.5 ± 1.7 ††† 28606 ± 1074 42.2 ± 5.5 † 63.5 ± 3.7 - - - - -
MitoPY1 + 10 47.2 ± 4.7 32162 ± 1353 13.9 ± 2 63.7 ± 2.9 8 33.6 ± 1.9 *§§ 37914 ± 772 *§ 15.8 ± 3.5§ 61.2 ± 2.2
Mock MitoPY1 + 6 50.2 ± 6.3 30223 ± 1708 11.9 ± 4.3 74.8 ± 6.3 6 13.0 ± 2.1 ** 31827 ± 1703 47.3 ± 7.1 ** 46 ± 5.6 **
Indo-1 + 15 61.9 ± 2.3 23953 ± 812 11.1 ± 1.5 75.1 ± 3.2 10 13.9 ± 1.7 ** 22832 ± 1525 58.2 ± 7.5 ** 39.7 ± 3.4 **
Indo-1 + CsA + 10 44.8 ± 3.2 †† 28152 ± 923 †† 24.5 ± 4.7 † 74.7 ± 4.2 - - - - -
1Ins: + or—indicates that 10 nmol/L insulin was present or not in the dye loading solution. Data are taken from the heart perfusions used in the relevant
surface fluorescence measurements and are given as means ± SEM for the number of hearts indicated. The absolute RPP and LVEDP values were
measured 1 min before the start of global ischaemia or IP. Recovery of RPP after 60 min reperfusion is expressed as a percentage of these preischemic
values.
* p 0.05
** p0.01 control vs IP
§ p0.05
§§ p0.01 MitoPY1 vs Mock MitoPY1
† p0.05
†† p0.01
††† p0.001 control vs control +CsA.
doi:10.1371/journal.pone.0167300.t001
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reverse electron flow mediated by the oxidation of succinate that accumulates during ischemia
[20,36]. In order to investigate this possibility we have monitored the redox state of NAD(P)H
and flavoproteins over the first two minutes of reperfusion using continuous acquisition at 10
Hz. In Fig 9 mean data (± SEM), normalised to the end ischemic value, are presented for con-
trol (n = 8) and IP hearts (n = 9). Since the fluorescence of NAD(P)H decreases on re-oxida-
tion (Panel A), while that of flavoproteins increases (Panel B), we also calculated the ratio
(Panel C) since this will reduce any errors caused by motion artefacts. In control hearts the
redox state of flavoproteins and NAD(P)H returned to pre-ischemic levels with a characteristic
and very reproducible multiphase pattern that included a very rapid initial oxidation (t0.5 < 10
s). In IP hearts re-oxidation showed only a single phase and was significantly slower than for
Fig 6. H2O2 production measured using PO1 fluorescence in control and IP hearts during ischemia /
reperfusion. A, Averaged fluorescence data for control (black) or IP (grey) hearts perfused with 5 μmol/L PO1.
PO1 was present in the perfusion solution from 30 min (Control) or 40 min (IP) before starting global ischemia. PO1
was excluded from the perfusion solution after 30 min of reperfusion. The fluorescence was normalized using the
value obtained at -11 min for control and -21 min for IP hearts and then averaged for each group. B, Mean data (±
SEM as error bars; n = 11 for control and n = 9 for IP hearts) for PO1 fluorescence during the reperfusion period. C,
Mean data (± SEM as error bars; n = 17 for control and n = 16 for CsA-treated hearts) for PO1 fluorescence during
reperfusion of control hearts (black) and CsA-treated hearts (grey). Data were normalized to the fluorescence value
at -16 min. Where present, CsA (0.2 mmol/L) was added to the PO1 perfusion solution 15 min before ischemia and
during 30 min of reperfusion. Statistically significant effects of IP and CsA are shown by the horizontal lines (*
p 0.05; ** p 0.01). Corresponding infarct sizes are presented in Table 1.
doi:10.1371/journal.pone.0167300.g006
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control hearts (t0.5 ~15 s). We have also measured the levels of succinate in hearts and found
pre-ischemic values were below our limit of detection (~0.2 nmol/mg dry weight (dw)) but
increased to 4.82 ± 0.47 nmol/mg dw (n = 6) after 30 min ischemia as described by Chouchani
et al [20]. However, a similar increase in succinate to 3.91± 0.38 nmol/mg dw (n = 6) was also
observed in IP hearts subject to 30 min ischemia arguing against reverse electron from succi-
nate being the source of ROS at complex 1 that is modulated by IP.
Measurement of intracellular [Ca2+] during ischemia / reperfusion using
Indo-1
We monitored [Ca2+]i using Indo-1 and it is important to note that some of this dye loads into
mitochondria [26] and thus its response may reflect changes in mitochondrial as well as cyto-
solic [Ca2+]. Fig 10 shows individual traces for changes in the Indo-1 ratio corrected for back-
ground autofluorescence in control (panel A) and IP (panel B) hearts. In both cases, during
the first 2–3 min of ischemia the Indo-1 ratio rises and then decreases again before rising con-
tinuously until the end of 30 min of ischemia. Since the binding of Ca2+ to Indo-1 is pH sensi-
tive [37], the decrease in pH during ischemia could initially attenuate or reverse any increase
caused by an increase in cytosolic [Ca2+]. Indeed, this may account for the initial rise and fall
in signal. Nevertheless, the continuous rise between 5–30 min of ischemia does reflect a real
and progressive increase in [Ca2+], but importantly there is no significant difference between
control and IP hearts. However, a major difference in cytosolic [Ca2+] between control and IP
hearts is seen upon reperfusion as highlighted in Fig 10C where mean data (± SEM) for 15 con-
trol hearts and 10 IP hearts are presented. In both cases the signal initially drops rapidly, most
likely reflecting a decrease in cytosolic [Ca2+] as it is removed from the cytosol by export from
the cells and uptake into the SR and re-energized mitochondria. Indeed, in a separate set of
experiments in which we isolated mitochondria at 90 s of reperfusion under conditions that
maintain their calcium content, we found that the total matrix calcium (ngatoms/mg protein
and means ± SEM) increased from 0.380 ± 0.028 in preischemic hearts to 0.501 ± 0.022 and
0.486 ± 0.054 in control and IP hearts respectively (Fig 11A).
Fig 7. Measurement of mitochondrial H2O2 in cardiomyocytes using MitoPY1. Confocal imaging of
cardiomyoytes loaded with MitoTracker Deep Red and MitoPY1 before and after H2O2-challenge. H2O2 (100 μmol/
L) was added directly to the coverslips and incubated for 10 min before re-imaging again. Scale bars: 20 μm, top
panels and 5 μm, bottom panels. As expected, the MitoPY1 signal was low in the basal state but increased
substantially upon addition of H2O2. The high resolution image (bottom panel) reveals individual interfibrillar
mitochondria and the overlay of green MitoPY1 signal and red Mitotracker signal (right panels) confirms the dye’s
mitochondrial localisation.
doi:10.1371/journal.pone.0167300.g007
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As reperfusion continued the Indo-1 signal stayed low in IP hearts (infarct size 13.9 ± 1.7%)
with only a gradual increase upon reperfusion, whereas in control hearts (infarct size 61.9 ±
2.3%), the signal began to rise rapidly after about 2 min, although with substantial variation
between hearts as seen in Fig 10A. This rise probably occurs after mPTP opening since we
have shown previously, using the deoxyglucose entrapment technique, that mPTP opening
begins within 2 min of reperfusion and is largely prevented by IP [23]. However, in order to
confirm this to be the case under our current experimental conditions, we isolated mitochon-
dria from hearts loaded with calcein (S1 Fig). The calcein-AM that enters mitochondria in situ
will be trapped within them following AM ester hydrolysis, but will be lost following mPTP
Fig 8. Measurement of mitochondrial H2O2 following ischemia / reperfusion in the perfused heart using
MitoPY1 and aconitase activity. A, MitoPY1 fluorescence (535 nm) in control (black) and IP (grey) in Langendorff-
perfused hearts subjected to 30 min ischemia + 30 min reperfusion. Fluorescence was normalized to the 1 min pre-
iscaemic value. MitoPY1 was successfully loaded into the hearts as shown by the increase in fluorescence upon
addition of H2O2 to the perfusion medium. B, Mean 535 nm fluorescence (± SEM as error bars) was normalized to
the average value between 20.5 and 21.5 min obtained on reperfusion after 30 min global ischemia in control (black,
n = 10) and IP hearts (grey, n = 8). C, Corresponding autofluorescence data for hearts subject to a mock loading
protocol (n = 6 in both control and IP hearts). Corresponding infarct sizes are presented in Table 1. D, Aconitase
activity in mitochondria isolated from normoxic control hearts (Cont) and both control (CP Rep) and ischemic
preconditioned (IP Rep) hearts subjected to 30 min ischemia and 90 s reperfusion as described in S1 Fig The grey
bars confirm the reduction in aconitase activity following treatment of the mitochondrial extract with 200 μmol/L
H2O2. Data are given as means ± SEM (error bars) of 4 hearts in each group.
doi:10.1371/journal.pone.0167300.g008
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Fig 9. Rapid re-oxidation of NAD(P)H and flavoproteins upon reperfusion of control and IP hearts following
30 min global ischemia. Data are presented as means ± SEM (error bars) of 8 control and 9 IP hearts (* p<0.05;
** p<0.01). S2 Table presents mean data for the corresponding values at 1 min before ischemia and at 2, 10 and 30
min of reperfusion, while a full representative trace for each parameter is given in S2 Fig
doi:10.1371/journal.pone.0167300.g009
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Fig 10. Measurement of [Ca2+] using Indo-1 in control and IP hearts during ischemia / reperfusion. Indo-1
fluorescence ratio corrected for autofluorescence was monitored in control (A) and IP (B) hearts undergoing 30 min
global ischemia and reperfusion. C, Mean data (± SEM as error bars) for control (black, n = 15), IP (light grey,
n = 10) and CsA-treated hearts (dark grey, n = 10) during the last 10 min of ischemia and 30 min of reperfusion. In
CsA-treated hearts, 0.2 μmol/L CsA was present in the perfusion medium for 10 min before ischemia and for 30 min
of reperfusion (n = 10). Corresponding infarct sizes are presented in Table 1.
doi:10.1371/journal.pone.0167300.g010
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opening and isolation of mitochondria. At 90 s of reperfusion mitochondria isolated from con-
trol I/R hearts showed significantly less entrapped calcein than mitochondria from pre-ische-
mic hearts (Fig 11B). This confirms that some mPTP opening had occurred at this time,
whereas for IP hearts this was not the case, consistent with inhibition of mPTP opening. These
data support our conclusion that the onset of the rise in cytosolic [Ca2+] during reperfusion
follows rather than precedes mPTP opening. Additional evidence for this is provided by the
data of Fig 10D which shows that the presence of 0.2 μmol/L CsA prior to ischemia and during
reperfusion to inhibit mPTP opening, also largely prevented this [Ca2+] rise while reducing
infarct size from 61.9 ± 2.3 to 44.8 ± 3.2%.
Opening of the mPTP in isolated heart mitochondria induces ROS
formation
Our data suggest that the major rise in ROS and [Ca2+] observed after the first few minutes of
reperfusion is a consequence of mPTP opening. In Fig 12 we present data to confirm that
opening of the mPTP does greatly enhance ROS production and release accumulated [Ca2+],
consistent with this prediction. Isolated heart mitochondria were energised with glutamate +
malate and succinate (GMS) to mimic the substrate availability in situ [28], and simultaneous
measurements made of light scattering (LS), mitochondrial membrane potential (ΔCm) and
extramitochondrial [Ca2+]. Parallel experiments monitored H2O2 emission with Amplex Red
and LS. Fig 12A shows that sequential additions of 100 μmol/L Ca2+ were rapidly taken up by
the mitochondria with a progressive reduction in ΔCm and consequently ROS production rate
until the mPTP opened (rapid and total loss of ΔCm, release of accumulated Ca
2+ and a large
LS decrease). At this point, ROS production greatly increased again. These data are quantified
in Fig 12B.
Discussion
Although it is widely accepted that increases in mitochondrial matrix [Ca2+] and ROS trigger
mPTP opening early in reperfusion [3,4], this has not been adequately demonstrated in the
beating perfused heart subject to ischemia and reperfusion. The bespoke surface fluorescence
equipment we describe in this paper, together with a robust experimental approach has
allowed us to address many of the substantial challenges associated with such measurements.
Our data lead us to the conclusion that reduction in ROS and [Ca2+] early in reperfusion may
not be the primary mechanism by which IP inhibits mPTP opening.
Validation and limitations of surface fluorescent techniques to measure
ROS and Ca2+ during ischemia / reperfusion of the beating heart
Although major changes in surface reflectance signals were detected in response to ischemic
contracture, they were not accompanied by significant changes in NAD(P)H and flavoprotein
autofluorescence (Fig 3A). This confirms the reliability of our fluorescence measurements
even in the face of the significant changes in optical geometry occurring at the onset of both
ischemia and reperfusion. Concerns over fluorescence artefacts caused by changes in internal
filtering by myoglobin and cytochromes during ischemia and reperfusion were addressed by
Fig 11. Measurement of total calcium content, entrapped calcein and citrate synthase activity in
mitochondria isolated from control and IP hearts after ischemia / reperfusion. Mitochondria were
isolated from normoxic control hearts (Cont) and both control (CP Rep) and IP (IP Rep) hearts subject to 30
min ischemia and 90 s reperfusion as described in S1 Fig. Data are given as means ± SEM (error bars) of 4
hearts in each group.
doi:10.1371/journal.pone.0167300.g011
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measuring the fluorescence emission spectrum from the surface of the heart in pre-ischemic
hearts and at different times of ischemia and reperfusion (Fig 4). The data show that
although there are potential artefacts caused by such changes, they are likely to affect only
the first few seconds of ischemia and reperfusion and most importantly to be similar in con-
trol and IP hearts. Furthermore, we employed two different ROS-fluorescent dyes with dis-
tinct spectral properties and ROS specificity: 5-cH2DCFDA (loaded as diAM), whose
oxidation occurs in response to oxidative stress but which may not directly monitor ROS
[31,32], and the H2O2 specific probe, PO1 [33]. Reassuringly, we obtained similar data with
both. In the case of 5-cH2DCFDA we also performed parallel experiments with the ROS-
insensitive dye calcein, which has similar fluorescent properties to 5-cDCFDA, and con-
firmed that it did not show a similar increase in fluorescence on reperfusion. Thus we are
confident that the time course of ROS change we observe with both dyes accurately reflects
global changes in ROS.
Measurements of [Ca2+] using the 405/485 nm fluorescence emission ratio of Indo-1 are
relatively insensitive to changes in the internal filtering effects caused by changes in myoglobin
oxygenation or cytochrome oxidation state (Fig 4). In addition, we performed parallel experi-
ments in the absence of Indo-1 (at the same instrument settings) to correct for changes in
autofluorescence. We have not attempted to correct for the influence of pH on the response of
Indo-1 to [Ca2+] since we are interested in detecting major differences between control and IP
hearts rather than absolute [Ca2+] values, and differences in pH are unlikely to explain the abil-
ity of IP to prevent the large increases in [Ca2+] observed later in reperfusion.
We recognise that an additional limitation of our surface fluorescence measurements is
their restriction to measuring ROS and [Ca2+] changes in the epicardium, but this is true of
any optical technique that uses emission and excitation wavelengths close to 500nm. It is also
possible that the magnitude and time courses of fluorescence changes observed in the epicar-
dium may not exactly mirror those in more internal layers of the ventricle wall. However, our
measurements of mitochondrial aconitase activity and calcium content suggest that any such
differences would not significantly affect our conclusions since mitochondria were isolated
from the whole ventricle and these show effects entirely consistent with those obtained by the
fluorescence measurements. Thus at 90 s of reperfusion, no change in aconitase activity was
detected (Fig 8D) in agreement with our inability to detect significant ROS increases with
5-cH2DCFDA (Fig 5C), PO1 (Fig 6B) or MitoPY1 (Fig 8B). Nor did IP attenuate the increase
in mitochondrial Ca2+ content on reperfusion (Fig 11A) consistent with no change in the
Indo-1 fluorescence data at this time point (Fig 10C).
The role of reverse electron flow in superoxide production at complex 1
Chouchani et al. [20] have proposed that superoxide production occurs early in reperfusion
from the matrix face of Complex 1 which they suggest is maintained in a highly reduced state
by reverse electron flow mediated by the oxidation of the succinate that accumulates during
ischemia [20,36]. However, our measurements of the redox state of NAD(P)H and flavopro-
teins in the first two minutes of reperfusion (Fig 9) revealed that they were both very rapidly
Fig 12. ROS production by isolated mitochondria before and after MPTP opening. A, Effects of
sequential additions of Ca2+ (100 mmol/L) to isolated rat heart mitochondria incubated with 5 mmol/L L-
glutamate + 2 mmol/L L-malate and 5 mmol/L succinate (GMS) on mPTP opening measured as the loss of
ΔΨ (Rhd-123 fluorescence increase) or accumulated Ca2+ (Fura-FF fluorescence increase) and decrease in
LS. ROS production was determined using Amplex Red in a parallel experiment on the same batch of
mitochondria. B, Mean rates of ROS production (± SEM of 6 different mitochondrial preparations) before Ca2+
addition, after the penultimate Ca2+ addition and following pore opening. ** p 0.01.
doi:10.1371/journal.pone.0167300.g012
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re-oxidised (t0.5 < 15 s) and that this re-oxidation was slower in IP than control hearts. This
would appear to be inconsistent with IP reducing superoxide production during early reperfu-
sion. However, the data are consistent with IP enhancing inhibition of the mitochondrial ATP
synthase by its inhibitor IF1 during ischemia, as has been observed in some studies (see [38])
since this could lead to slower activation of oxidative phosphorylation and respiration on
reperfusion. Furthermore, the accumulation of succinate during 30 min ischemia was not pre-
vented by IP (3.91± 0.38 nmol/mg dw (n = 6) compared to 4.82 ± 0.47 nmol/mg dw (n = 6) in
controls). Thus if an increase in ROS is occurring early in reperfusion to stimulate mPTP
opening our data suggest it is not a result of reverse electon flow from succinate leading to
increased superoxide production at Complex 1. We next address whether such an increase in
matrix ROS early in reperfusion does occur prior to initial mPTP opening.
Detectable ROS increases start at 2–3 min of reperfusion, after mPTP
opening, and are inhibited by IP and CsA
A wealth of published data, including our own [3], led us to anticipate that we would observe a
significant increase in ROS immediately on reperfusion that would act as a trigger for mPTP
opening, and that this would be reduced by IP. However, neither 5-cDCFDA nor PO1 signals
began to rise consistently until 2–3 min of reperfusion (Figs 5C and 6C) which is after mPTP
opening occurs, as revealed in early experiments by increased entrapment of 2-deoxyglucose
[2] and in the present experiments by release of entrapped calcein (Fig 11B). It is possible that
5-cDCFDA and PO1 are insufficiently sensitive to detect any small early increases in mito-
chondrial matrix ROS that might be responsible for triggering mPTP opening. However, our
measurements of NAD(P)H and flavoproteins autofluorescence during the first phase of
reperfusion do not suffer these limitations. As noted above, these data reveal that NAD(P)H
and flavoproteins are oxidised very rapidly (t0.5 < 10 s) and so would be unlikely to generate
significant ROS after the first few seconds of reperfusion. Equally important is the observation
that the rate of oxidation of NAD(P)H and flavoproteins is slower in IP hearts than in control
hearts. If complex 1 were producing a rapid burst of ROS responsible for triggering mPTP
opening our data would predict greater ROS production in the mitochondria of IP hearts and
thous would be expected to enhance rather than impair mPTP opening. Furthermore, we were
unable to detect any significant increase in mitochondrial H2O2 using the targeted probe
MitoPY1 (Fig 8B) or aconitase activity (Fig 8D) after 90 s of reperfusion. Again, we recognize
that these techniques suffer limitations. Thus loading with MitoPY1 appeared to have addi-
tional “off-target” effects that modulate the infarct size (Table 1), most notably increasing it in
IP hearts from 13.2 ± 2.1% to 33.6 ± 1.9%. Nor can we completely rule out the possibility that
the sensitivity and kinetics of the reaction of MitoPY1 and aconitase with H2O2 are sufficient
to detect any small increases in matrix H2O2 early in reperfusion that might trigger mPTP
opening. A compounding factor for MitoPY1 is that small changes in its signal during the first
10–20 seconds of reperfusion could be masked by major changes in internal filtering caused
by myoglobin re-oxygenation that occurs over this time period [17] as well as by rapid changes
in autofluorescence (Fig 8C). Nevertheless, even taking these limitations into account, our data
clearly show that any changes in mitochondrial matrix ROS in early reperfusion must be very
small compared with those observed later in reperfusion. It should be noted that although
Chouchani et al. [20] did detect an increase in H2O2 using the mitochondrial-targeted boro-
nate cage reagent MitoB and aconitase activity, this was measured at 15 min of reperfusion,
again after mPTP opening has peaked [2] and when our own data confirm that a significant
increase in ROS has occurred. However, it is also important to note that our data do not rule
out the possibility that there is a rapid burst of superoxide production in the early stages of
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reperfusion which is immediately removed by endogenous defense mechanisms such as super-
oxide dismutase working in combination with glutathione peroxidase and glutathione reduc-
tase. The subsequent rises in ROS we observe later in reperfusion might reflect the exhaustion
of these defence mechanisms.
Overall, our data suggest that any increases in mitochondrial matrix H2O2 early in reperfu-
sion are too small to be detected by the techniques we employed and thus are unlikely to medi-
ate the initial IP-inhibitable opening of the mPTP. This may explain why our earlier studies
with the mitochondria-targeted superoxide scavenger, MitoQ, failed to demonstrate cardio-
protection in the Langendorff-perfused heart [39]. It should be noted that earlier data showing
protection from I/R injury of the heart by MitoQ was obtained in a whole animal model in
which rats were treated for 14 days with mitoQ in their drinking water before induction of
myocardial ischemia [40]. Thus the observed cardioprotective effects of the drug in these
experiments could be secondary to its longer term effects and not directly via mitochondrial
ROS scavenging in the heart. Rather, our data suggest that the observed increase in ROS on
reperfusion detected with both 5-cDCFDA (Fig 5C) and PO1 (Fig 6B) occurs after mPTP
opening and is attenuated by IP and CsA as a secondary response to their inhibition of pore
opening. It should be noted that superoxide production occurring after mPTP opening,
whether in the matrix or the intermembrane space, will be detected by extramitochondrial
ROS probes such as 5-cDCFDA and PO1 that we employed.
The reduction in ROS caused by IP is considerably greater than that by CsA (Fig 6C) and
this matches the relative ability of IP and CsA to prevent mPTP opening on reperfusion as
determined with the 2-deoxyglucose entrapment protocol [23]. The data we present in Fig 12
confirm that increased ROS production does occur following mPTP opening in isolated heart
mitochondria as has previously been reported [41]. It is probably the result of cytochrome c
and NADPH loss from the mitochondria, both of which are important for ROS scavenging
[21,41]. Indeed it has been proposed that such mPTP-mediated ROS production drives pro-
gressive mPTP opening in adjacent mitochondria and cells leading to an expanding wave of
necrotic cell death as reperfusion continues [3,41]. However, the presence of ROS scavengers
during reperfusion has proved to be relatively ineffective at preventing IR in either the clinical
setting or with in vivo and ex vivo animal models of IR [42,43]. A better understanding of the
mechanisms leading to ROS production later during the reperfusion phase may help the devel-
opement of drugs that inhibit this process more effectively, although a role of ROS in cardio-
protective signalling pathways [43,44] may work against this strategy. Furthermore, it is also
possible that mPTP-induced ROS production is less important in causing a progressive cas-
cade of mPTP opening than the dysregulation of [Ca2+] discussed below.
IP inhibits the large increases in [Ca2+] during reperfusion that occur
after mPTP opening
Another major trigger for mPTP opening is matrix [Ca2+]. As predicted, we did detect an
increase in Indo-1 ratio during ischemia, consistent with a rise in cytosolic and mitochondrial
[Ca2+], and this was followed by a return to basal at the start of reperfusion (Fig 10A), most
likely reflecting cytosolic calcium efflux from the cardiomyocytes and / or uptake into mito-
chondria and other intracellular stores. Similar data were obtained with 20 min ischemia by
Hassinen’s group using Fura-2, but this dual wavelength excitation indicator (340/380ex,
>515em) requires much greater corrections for autofluorescence than Indo-1 [30,45]. We were
also able to demonstrate that mitochondria isolated after 90 s of reperfusion contained more
calcium than pre-ischemic hearts consistent with calcium being an important trigger for
mPTP opening. However, our data revealed that the increase in [Ca2+] during ischemia in IP
Effects of Ischemic Preconditioning on ROS and Ca2+ in Ischemic / Reperfused Hearts
PLOS ONE | DOI:10.1371/journal.pone.0167300 December 1, 2016 24 / 31
hearts was similar to that in control hearts (Fig 10A and 10B), as was the total calcium content
of mitochondria isolated at 90 s of reperfusion (Fig 11A). Thus it is unlikely that IP modulates
mPTP opening on reperfusion by attenuating [Ca2+] within the mitochondrial matrix. Never-
theless, after 2–3 min of reperfusion, control hearts did show a profound and progressive
increase in Indo-1 ratio which was not observed in IP hearts (Fig 10C). This large rise in [Ca2
+] later in reperfusion, like that of ROS, is likely to be secondary to mPTP opening and proba-
bly reflects energy compromise in cells following mPTP opening with subsequent impairment
of ionic homeostasis. Indeed we show that treatment of hearts with CsA to inhibit mPTP open-
ing also largely prevented the observed increase in [Ca2+] on reperfusion (Fig 10C). Similar
observations have been made by others using an isolated myocyte model of ischemia / reperfu-
sion [46]. The dysregulation of intracellular [Ca2+] following initial mPTP opening may act in
conjunction with the rise in ROS to cause additional mPTP opening in adjacent “unopened”
mitochondria and lead to a progressive wave of cell death as discussed above. This may explain
the waves of [Ca2+] and ROS preceding mPTP opening that have been observed by confocal
microscopy in the intact contraction-inhibited heart subject to hypoxia and reoxygenation
[18].
It is important to stress that our data do not rule out a role for mitochondrial Ca2+ accumu-
lation at the end of ischemia and during early reperfusion in mPTP opening. Such increases in
matrix [Ca2+] have been demonstrated previously in both cardiac myocytes [47] and perfused
hearts [48] and confirmed here (Fig 11A). Indeed, hearts of mice with an adult cardiomyocyte-
specific deletion of the mitochondrial calcium uniporter (MCU) have recently been shown to
exhibit reduced IR injury [49,50] confirming earlier data obtained with the MCU inhibitors
ruthenium red and Ru360 [51,52]. However, what our data do imply is that inhibition of
mPTP opening by IP is unlikely to be secondary to decreased matrix calcium overload, but
rather by decreased sensitivity to matrix [Ca2+].
Implications for cardioprotection by therapeutic interventions
Prevention of mPTP opening at reperfusion is widely regarded as a promising target for cardi-
oprotection [3,8]. In the context of cardiac surgery, preconditioning (ischemic and pharmaco-
logical) is feasible but this is not the case for treating a coronary thrombosis by percutaneous
coronary intervention (PCI–also called angioplasty). This may explain why clinical trials failed
to show a significant cardioprotective effect of CsA given intravenously prior to the treatment
of coronary thrombosis with PCI [53]. However, under these conditions, ischemic post-condi-
tioning may be effective. Here the relevant coronary arteries are subject to short transient
cycles of blood flow and occlusion for the first few minutes of reperfusion [54]. Although the
mechanisms underlying ischemic post-conditioning are not fully elucidated, it has been
shown to be associated with inhibition of mPTP opening. This may be partially explained by
maintenance of an acid pH (inhibitory for mPTP opening) for longer during the early stages
of reperfusion, but other signalling pathways are also thought to be involved [44,55]. There are
no published data to show that reduced ROS production during the early stages of reperfusion
post-conditioning is the mechanism by which it inhibits mPTP. However, this is not unex-
pected in view of our inability to detect increases in ROS early in reperfusion. Although we
have not confirmed it experimentally, we would suggest that no matter how post-conditioning
inhibits the first phase of mPTP opening, it would prevent secondary ROS production and
dysregulation of [Ca2+] with less subsequent mPTP opening and thus reduced infarct forma-
tion. Indeed, our data lead us to predict that any protocl employed during reperfusion that
reduces disturbances in ROS and calcium during the later phase of the reperfusion should be a
good strategy to limit further mPTP opening and thus provide cardioprotection.
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Fig 13. Schematic to show proposed sequence of events relating ischemia and reperfusion to mPTP
opening and increases in ROS and [Ca2+]. Events confirmed in the present paper are shown in lilac and those
previously reported in [21] are shown in mauve.
doi:10.1371/journal.pone.0167300.g013
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Conclusions
Taken together, our data suggest that any changes in [Ca2+] or ROS early in reperfusion that
might trigger mPTP opening are small compared with those later in reperfusion, and not
attenuated by IP. If this is the case, IP would have to work through alternative mechanisms to
attenuate initial mPTP opening. One such established mechanism involves hexokinase 2
(HK2) whose binding to mitochondria is associated with resistance to mPTP opening
[22,56,57] and also with stabilisation of contact sites between the inner and outer membrane
whose breakage may enhance cytochrome c release [56,58]. HK2 is known to dissociate from
heart mitochondria during reperfusion and this is prevented by IP [21,22,56,57]. Indeed, there
is a very strong inverse correlation between the amount of HK2 remaining bound to mito-
chondria at the end of ischemia and the infarct size after 120 min of reperfusion [21]. We pro-
pose that it may be these changes to the mitochondria together with the elevated [Ca2+]
present at the end of ischemia and during early reperfusion that sensitise mitochondria to
mPTP opening. As reperfusion continues, the intracellular pH returns to control values (>7)
from end-ischemic values (< 6.5) that inhibit mPTP opening. As a result, mPTP opening now
occurs and leads to the observed secondary increase in ROS release. In addition, through
impaired energy metabolism and consequent dysregulation of calcium homeostasis, a large
rise in [Ca2+] occurs. These secondary changes in [Ca2+] and ROS, will then trigger mPTP
opening in adjacent mitochondria and neighbouring cells leading to a spreading wave of
mPTP opening and increasing infarct size as reperfusion continues. IP, by preventing the HK2
loss and contact site destabilization during ischemia, will prevent these secondary increases in
[Ca2+] and ROS and thus attenuate the resulting cell death and infarct development. This is
illustrated schematically in Fig 13. We have suggested previously how a wide range of cardio-
protective strategies and signalling pathways may exert their effects through this common
pathway [56].
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